Applicability of second‐generation colon capsule endoscope to ulcerative colitis: A clinical feasibility study. Issue 7 (20th June 2013) - Hosoe, Naoki
Abstract Background and Aim Colon capsule endoscopy has already been used for colon visualization and detection of polyps but its applicability to inflammatory bowel disease is still unconfirmed. The aim of this study was to assess the feasibility of evaluating the severity of mucosal inflammation in patients with ulcerative colitis (UC) using a second‐generation colon capsule endoscope (CCE‐2). Methods Forty patients with histological confirmed diagnosis of UC were enrolled. Low‐volume (2 L) polyethylene glycol solution with prokinetics (mosapride citrate and metoclopramide) regimen was used for the bowel preparation. In Phase 1, consisting of 10 patients, to confirm appropriate CCE‐2 bowel preparation for UC. In Phase 2, consisting of 30 patients, CCE‐2 was performed with a fixed bowel preparation regimen. CCE‐2 findings were recorded for 8 h starting from capsule ingestion and conventional colonoscopy was subsequently performed on the same day. CCE‐2 procedure completion rate and the colon cleansing level with a 4‐point grading scale (poor, fair, good, and excellent) were evaluated in Phase 2. Correlations between Matts endoscopic scores as judged by CCE‐2 and conventional colonoscopy were calculated. Results CCE‐2 procedure was completed within 8 h in 69% of the patients. The proportion of patients with good or excellent cleansing level was below 50%. However, Matts endoscopic scores determined by CCE‐2 showed a strong correlation with scores obtained by conventional colonoscopy (average ρ = 0.797). Conclusions Although modifications in bowel preparation are needed, CCE‐2 might be feasible for assessing the severity of mucosal inflammation in patients with UC.